The EMA’s human medicines committee recommended 114 medicines for approval in 2024, marking the highest number of positive opinions issued in 15 years ...
Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers stock in trouble, or is this just a bump in the road for what could still ...
Hims & Hers makes it easy for patients to buy a growing list of prescription medications on its website ... service to help treat areas such as erectile dysfunction and hair loss, which are ...
Before the advent of medications, individuals with these more extreme symptoms often found themselves stuck—unable to engage meaningfully in therapy or, in many cases, requiring long-term ...
First-in-class drugs are therapies that utilize novel mechanisms of action, offering new approaches to challenging diseases. In 2024, the U.S. Food and Drug Administration (FDA) approved 50 new ...
What Are Insulin Sensitivity Drugs? Insulin sensitivity refers to how sensitive your body is to the hormone insulin. Impaired insulin sensitivity, also called insulin resistance, is when cells in ...